InsiderTrades

Form 4 for IMDX Insight Molecular Diagnostics Inc.

Accepted 2022-12-09 00:00:00 ET · period of report 2022-12-01 · accession 0001493152-22-035089 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-12-09 2022-12-01 IMDX ANDREWS RONALD ASBURY Former CEO, Dir M - OptEx $0.00 +250.0K 583.2K +75% $0
D 2022-12-09 2022-12-01 IMDX ANDREWS RONALD ASBURY Former CEO, Dir M - OptEx $0.00 -250.0K 0 -100% $0
D 2022-12-09 2022-12-07 IMDX ANDREWS RONALD ASBURY Former CEO, Dir A - Grant $0.00 +50.0K 50.0K New $0
DM 2022-12-09 2022-12-01 IMDX ANDREWS RONALD ASBURY Former CEO, Dir D - Sale to Iss $0.00 -2.24M 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock, no par value 2022-12-01 M A 250,000 $0.00 583,212 D — —
2 Derivative Restricted Stock Units 2022-12-01 M D 250,000 $0.00 0 D $0.00 · — to — 250,000 Common Stock (F2) The restricted stock units were forfeited by mutual agreement of the Reporting Person and the Issuer in connection with a severance agreement entered into as a result of the Reporting Person's resignation as an officer and director of the Issuer on December 1, 2022. Any remaining restricted stock units immediately vested on December 1, 2022.
3 Derivative Option to Purchase Common Stock 2022-12-07 A A 50,000 $0.00 50,000 D $0.46 · — to 2032-12-07 50,000 Common Stock (F3) Options vest (and thereby become exercisable) as follows: (i) one-third on December 31, 2022, (ii) one-third on January 31, 2023, and (iii) one-third on February 28, 2023 (each such date, a "Vesting Date"), in each case, subject to the Reporting Person's continuous service as a consultant on each applicable Vesting Date.
4 Derivative Option to Purchase Common Stock 2022-12-01 D D 300,000 $0.00 0 D $1.15 · — to — 300,000 Common Stock (F1) The options were forfeited by mutual agreement of the Reporting Person and the Issuer in connection with a severance agreement entered into as a result of the Reporting Person's resignation as an officer and director of the Issuer on December 1, 2022. Any remaining options immediately vested and became exercisable as of December 1, 2022.
5 Derivative Option to Purchase Common Stock 2022-12-01 D D 500,000 $0.00 0 D $5.34 · — to — 500,000 Common Stock (F1) The options were forfeited by mutual agreement of the Reporting Person and the Issuer in connection with a severance agreement entered into as a result of the Reporting Person's resignation as an officer and director of the Issuer on December 1, 2022. Any remaining options immediately vested and became exercisable as of December 1, 2022.
6 Derivative Option to Purchase Common Stock 2022-12-01 D D 20,000 $0.00 0 D $2.10 · — to — 20,000 Common Stock (F1) The options were forfeited by mutual agreement of the Reporting Person and the Issuer in connection with a severance agreement entered into as a result of the Reporting Person's resignation as an officer and director of the Issuer on December 1, 2022. Any remaining options immediately vested and became exercisable as of December 1, 2022.
7 Derivative Option to Purchase Common Stock 2022-12-01 D D 50,000 $0.00 0 D $1.68 · — to — 50,000 Common Stock (F1) The options were forfeited by mutual agreement of the Reporting Person and the Issuer in connection with a severance agreement entered into as a result of the Reporting Person's resignation as an officer and director of the Issuer on December 1, 2022. Any remaining options immediately vested and became exercisable as of December 1, 2022.
8 Derivative Option to Purchase Common Stock 2022-12-01 D D 950,000 $0.00 0 D $2.51 · — to — 950,000 Common Stock (F1) The options were forfeited by mutual agreement of the Reporting Person and the Issuer in connection with a severance agreement entered into as a result of the Reporting Person's resignation as an officer and director of the Issuer on December 1, 2022. Any remaining options immediately vested and became exercisable as of December 1, 2022.
9 Derivative Option to Purchase Common Stock 2022-12-01 D D 93,750 $0.00 281,250 D $1.15 · — to — 93,750 Common Stock (F1) The options were forfeited by mutual agreement of the Reporting Person and the Issuer in connection with a severance agreement entered into as a result of the Reporting Person's resignation as an officer and director of the Issuer on December 1, 2022. Any remaining options immediately vested and became exercisable as of December 1, 2022.
10 Derivative Restricted Stock Units 2022-12-01 D D 35,000 $0.00 0 D $0.00 · — to — 35,000 Common Stock (F2) The restricted stock units were forfeited by mutual agreement of the Reporting Person and the Issuer in connection with a severance agreement entered into as a result of the Reporting Person's resignation as an officer and director of the Issuer on December 1, 2022. Any remaining restricted stock units immediately vested on December 1, 2022.
11 Derivative Restricted Stock Units 2022-12-01 D D 250,000 $0.00 250,000 D $0.00 · — to — 250,000 Common Stock (F2) The restricted stock units were forfeited by mutual agreement of the Reporting Person and the Issuer in connection with a severance agreement entered into as a result of the Reporting Person's resignation as an officer and director of the Issuer on December 1, 2022. Any remaining restricted stock units immediately vested on December 1, 2022.
12 Derivative Option to Purchase Common Stock 2022-12-01 D D 45,000 $0.00 0 D $2.40 · — to — 45,000 Common Stock (F1) The options were forfeited by mutual agreement of the Reporting Person and the Issuer in connection with a severance agreement entered into as a result of the Reporting Person's resignation as an officer and director of the Issuer on December 1, 2022. Any remaining options immediately vested and became exercisable as of December 1, 2022.